These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31891614)

  • 21. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
    Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
    Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
    Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
    Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux.
    Ek WE; Levine DM; D'Amato M; Pedersen NL; Magnusson PK; Bresso F; Onstad LE; Schmidt PT; Törnblom H; Nordenstedt H; Romero Y; ; Chow WH; Murray LJ; Gammon MD; Liu G; Bernstein L; Casson AG; Risch HA; Shaheen NJ; Bird NC; Reid BJ; Corley DA; Hardie LJ; Ye W; Wu AH; Zucchelli M; Spector TD; Hysi P; Vaughan TL; Whiteman DC; MacGregor S;
    J Natl Cancer Inst; 2013 Nov; 105(22):1711-8. PubMed ID: 24168968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.
    Hao Y; Triadafilopoulos G; Sahbaie P; Young HS; Omary MB; Lowe AW
    Gastroenterology; 2006 Sep; 131(3):925-33. PubMed ID: 16952561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma.
    Becker J; May A; Gerges C; Anders M; Veits L; Weise K; Czamara D; Lyros O; Manner H; Terheggen G; Venerito M; Noder T; Mayershofer R; Hofer JH; Karch HW; Ahlbrand CJ; Arras M; Hofer S; Mangold E; Heilmann-Heimbach S; Heinrichs SK; Hess T; Kiesslich R; Izbicki JR; Hölscher AH; Bollschweiler E; Malfertheiner P; Lang H; Moehler M; Lorenz D; Müller-Myhsok B; Ott K; Schmidt T; Whiteman DC; Vaughan TL; Nöthen MM; Hackelsberger A; Schumacher B; Pech O; Vashist Y; Vieth M; Weismüller J; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J
    Cancer Med; 2015 Nov; 4(11):1700-4. PubMed ID: 26383589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.
    Ferrer-Torres D; Nancarrow DJ; Steinberg H; Wang Z; Kuick R; Weh KM; Mills RE; Ray D; Ray P; Lin J; Chang AC; Reddy RM; Orringer MB; Canto MI; Shaheen NJ; Kresty LA; Chak A; Wang TD; Rubenstein JH; Beer DG
    Gastroenterology; 2019 Apr; 156(5):1404-1415. PubMed ID: 30578782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.
    Buas MF; He Q; Johnson LG; Onstad L; Levine DM; Thrift AP; Gharahkhani P; Palles C; Lagergren J; Fitzgerald RC; Ye W; Caldas C; Bird NC; Shaheen NJ; Bernstein L; Gammon MD; Wu AH; Hardie LJ; Pharoah PD; Liu G; Iyer P; Corley DA; Risch HA; Chow WH; Prenen H; Chegwidden L; Love S; Attwood S; Moayyedi P; MacDonald D; Harrison R; Watson P; Barr H; deCaestecker J; Tomlinson I; Jankowski J; Whiteman DC; MacGregor S; Vaughan TL; Madeleine MM
    Gut; 2017 Oct; 66(10):1739-1747. PubMed ID: 27486097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
    Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
    BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
    Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
    Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.
    Palles C; Chegwidden L; Li X; Findlay JM; Farnham G; Castro Giner F; Peppelenbosch MP; Kovac M; Adams CL; Prenen H; Briggs S; Harrison R; Sanders S; MacDonald D; Haigh C; Tucker A; Love S; Nanji M; deCaestecker J; Ferry D; Rathbone B; Hapeshi J; Barr H; Moayyedi P; Watson P; Zietek B; Maroo N; Gay L; Underwood T; Boulter L; McMurtry H; Monk D; Patel P; Ragunath K; Al Dulaimi D; Murray I; Koss K; Veitch A; Trudgill N; Nwokolo C; Rembacken B; Atherfold P; Green E; Ang Y; Kuipers EJ; Chow W; Paterson S; Kadri S; Beales I; Grimley C; Mullins P; Beckett C; Farrant M; Dixon A; Kelly S; Johnson M; Wajed S; Dhar A; Sawyer E; Roylance R; Onstad L; Gammon MD; Corley DA; Shaheen NJ; Bird NC; Hardie LJ; Reid BJ; Ye W; Liu G; Romero Y; Bernstein L; Wu AH; Casson AG; Fitzgerald R; Whiteman DC; Risch HA; Levine DM; Vaughan TL; Verhaar AP; van den Brande J; Toxopeus EL; Spaander MC; Wijnhoven BP; van der Laan LJ; Krishnadath K; Wijmenga C; Trynka G; McManus R; Reynolds JV; O'Sullivan J; MacMathuna P; McGarrigle SA; Kelleher D; Vermeire S; Cleynen I; Bisschops R; Tomlinson I; Jankowski J
    Gastroenterology; 2015 Feb; 148(2):367-78. PubMed ID: 25447851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
    Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J
    Int J Cancer; 2016 Mar; 138(5):1146-52. PubMed ID: 26414697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma.
    Sepulveda JL; Komissarova EV; Kongkarnka S; Friedman RA; Davison JM; Levy B; Bryk D; Jobanputra V; Del Portillo A; Falk GW; Sonett JR; Lightdale CJ; Abrams JA; Wang TC; Sepulveda AR
    Int J Cancer; 2019 Nov; 145(10):2754-2766. PubMed ID: 31001805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
    Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
    Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Content Imaging of Barrett's-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions.
    Phipps SM; Garry CE; Kamal S; Johnson JD; Gilmer J; Long A; Kelleher D; Duggan SP
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):601-622. PubMed ID: 32416156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
    Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
    J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.